Menopause Supplements: Black Cohosh, Soy Isoflavones and Others: What Trials Show

The pharmacy aisle has changed shape. Where a single shelf of calcium once stood, there are now whole displays of menopause supplements promising “hormone-free balance,” and the social feeds of women in their late 40s are full of before-and-after testimonials for black cohosh gummies and soy isoflavone capsules. As of early 2026, searches for these products are at record levels, pushed by two developments: a wave of prescription approvals and label changes that put menopause back in the news, and a parallel surge of viral “natural alternative” videos that rarely mention a trial.

That gap between marketing and evidence is the story worth telling. Hot flashes are real, often disruptive, and for roughly three in four women they last years rather than months. The question is not whether the discomfort deserves treatment. It plainly does. The question is which bottles have earned a place on the shelf, which are harmless but idle, and which carry risks that the label does not shout about.

What follows is a plain reading of the randomized trials, the observational data and the expert statements, graded for strength, so you can walk into your next appointment with better questions than a hashtag can offer.

What changed recently to make menopause supplements trend

Three dated events explain the current spike. In May 2023 the US Food and Drug Administration approved fezolinetant, the first non-hormonal prescription medicine designed specifically for hot flashes. It works by blocking neurokinin-3 receptors, a set of switches in the brain’s temperature-control center that go into overdrive when estrogen falls. A second medicine in the same class followed in late 2025. For the first time, women who cannot or prefer not to take hormones had a prescription option built for the symptom rather than borrowed from psychiatry or neurology.

Then, in November 2025, the FDA announced it would remove the broad boxed warning about heart disease, breast cancer and dementia from most menopausal hormone therapy labels, saying the strongest warnings had been based on findings in older women that did not translate to women starting treatment close to menopause. Guideline-level sources such as the NHS and Mayo Clinic had already described hormone therapy as the most effective treatment for hot flashes, with benefits generally outweighing risks for healthy women under 60 or within ten years of their final period.

Each headline sent people searching, and search algorithms surfaced supplements alongside prescriptions. The evidence base for the supplements, however, has not moved much. The most recent systematic review of black cohosh from the Cochrane Collaboration still dates to 2012; the comparable Cochrane review of phytoestrogens, including soy isoflavones, dates to 2013. The NIH Office of Dietary Supplements fact sheet on black cohosh, updated since then, reaches the same conclusion: results are inconsistent and the better-designed trials tend to be the ones that find no effect.

In other words, the news is about prescriptions. The supplements are riding along in the slipstream.

What perimenopause and postmenopause actually feel like

Perimenopause is the transition before the final menstrual period, when ovarian hormone output becomes erratic rather than simply low. Cleveland Clinic puts the usual onset in the mid-40s, with a typical length of about four years, though anywhere from a few months to a decade is within normal. Starting at 40 is common and not a cause for alarm on its own; menopause before 45 is termed early, and before 40 it is called premature ovarian insufficiency, which does warrant medical evaluation because of its effect on bone and heart health.

Spotting between periods is one of the most searched symptoms, and the honest answer has two parts. Irregular bleeding is common in perimenopause because ovulation becomes unpredictable, so the uterine lining builds and sheds on a changed schedule. Yet very heavy bleeding, bleeding after sex, periods closer than three weeks apart, or any bleeding once you have gone twelve months without a period are not things to wait out; they need an examination.

Postmenopause begins after that twelve-month mark. Symptoms do not switch off at the boundary. The large Study of Women’s Health Across the Nation found hot flashes lasting a median of around seven years, and for women whose flashes started early in perimenopause, more than a decade. Other postmenopausal changes are quieter but more durable: vaginal dryness and urinary urgency from thinning tissue, broken sleep, mood shifts, and a drop in bone density that is steepest in the first few years after the final period. Joint aches and changes in skin and hair are frequently reported too.

Knowing which symptom you most want to fix matters, because the evidence for menopause supplements differs sharply from one symptom to the next. A product with a flicker of support for hot flashes may have none at all for sleep or bone.

What the evidence actually says: how to grade a menopause claim

Not all evidence weighs the same, and the menopause supplement market thrives on blurring the tiers. Here is the ladder clinicians climb when they judge a treatment.

At the top sits the randomized controlled trial, in which women are assigned by chance to the supplement or an identical-looking placebo, and neither they nor the researchers know who got what until the end. A systematic review pools many such trials to see whether the results agree. Below that come observational studies, which watch what people already do (eat soy, take an herb) and look for patterns; these can reveal associations but cannot prove cause, because people who choose supplements differ in income, diet and health from those who do not. Lower still are small uncontrolled studies and case series, and at the bottom are expert opinion and testimonials.

Applying that ladder to menopause supplements produces a sober picture. Black cohosh has been tested in multiple randomized trials; pooled, they show no reliable advantage over placebo, which is strong evidence of a weak or absent effect. Soy isoflavones have dozens of trials with inconsistent results; the pooled estimate suggests a small reduction in hot flash frequency in some analyses and none in others, so the evidence is graded as low to moderate certainty. Red clover sits in similar territory with fewer trials. Evening primrose oil and omega-3 fatty acids have been tested in good trials and failed to beat placebo. Vitamin E shows a tiny effect of doubtful clinical meaning. Maca, ginseng, DHEA and most multi-ingredient “menopause formulas” rest on small or no randomized data.

Vitamin D and calcium are a different case. The evidence that they protect bone when intake is low is robust; the evidence that they ease hot flashes is absent. The grade depends entirely on what you are asking the product to do.

Black cohosh for hot flashes: what the trials show

Black cohosh is a North American woodland plant whose root has been used for women’s complaints for more than a century, and it remains the most studied herbal menopause supplement. For years it was assumed to act like a weak plant estrogen. That idea has largely been abandoned; laboratory work now points to effects on serotonin and other brain signaling pathways, though no mechanism is settled.

The Cochrane review published in 2012 pooled 16 randomized trials involving 2,027 women. On the central outcome, the number of daily hot flashes, black cohosh performed no better than placebo. Nor did it improve standardized menopause symptom scores. The reviewers judged the overall quality of evidence low, partly because trials used different preparations and lasted only a few months. A frequently cited US trial funded by the NIH, the Herbal Alternatives for Menopause study, randomized women to black cohosh, a multibotanical mix, soy diet counseling, hormone therapy or placebo for a year. Hormone therapy cut hot flashes sharply; black cohosh did not separate from placebo at any time point.

Why, then, do so many women report relief? Part of the answer is the placebo response discussed later, which in hot flash trials routinely reaches 30 to 50 percent. Part is that a handful of European trials with one particular extract did report benefit, and these are the studies manufacturers quote. The NIH Office of Dietary Supplements summarizes the field this way: studies have produced inconsistent results, and those with more rigorous designs tend to be negative.

Safety is mostly reassuring for short-term use, with stomach upset, rash and headache the common complaints. The exception is a small number of case reports of liver injury, serious enough that regulators in several countries require a liver warning on the label. Causality is unproven, but anyone with liver disease, or who notices yellowing skin, dark urine or unusual fatigue while taking it, should stop and seek care.

Soy isoflavones and other phytoestrogens: a mixed verdict

Isoflavones are plant compounds, concentrated in soybeans, that are shaped enough like estrogen to attach weakly to the body’s estrogen receptors. The leading isoflavones are genistein and daidzein. Their appeal rests on a striking observation: women in Japan and other soy-eating cultures historically reported far fewer hot flashes than women in North America and Europe. Observational data, remember, shows association, not cause; diet, body size, climate and even the willingness to report symptoms all differ between those populations.

The randomized trials tell a more hesitant story. The 2013 Cochrane review of phytoestrogens pooled 43 trials with more than 4,000 participants and found no conclusive evidence that soy or red clover extracts reduce hot flashes, while noting that trials using extracts rich in genistein showed more promise than the rest. Later meta-analyses have reported modest average reductions in hot flash frequency, often reached only after 12 weeks or more, and with wide variation between studies. The NIH’s complementary health center describes the research as inconsistent and the effect, where present, as small.

One biological detail may explain the scatter. Daidzein is converted in the gut to a more potent compound called equol, but only by people who carry the right intestinal bacteria. Roughly a third of people in Western countries and about half in East Asian countries are “equol producers.” Trials that did not sort participants by this trait may have mixed responders with non-responders and diluted the signal. That is a hypothesis under study, not a reason to buy a product.

Soy foods such as tofu, edamame and soy milk are safe for nearly everyone and come with protein and fiber attached. Concentrated isoflavone supplements are another matter for women who have had estrogen-sensitive breast cancer: the observational data on soy foods is reassuring, but supplement-level doses have not been proven safe in that group, and the decision belongs with the oncology team.

Red clover, evening primrose, St John's wort and other herbal menopause supplements

Behind the two headliners sits a long bench of botanicals, most with thinner files.

Red clover supplies isoflavones of its own, and its trials mirror soy’s: a few positive, several null, pooled estimates that hover near the line of no effect. The Cochrane phytoestrogen review did not find persuasive benefit. Side effects are mild, but like any isoflavone source it deserves caution in women with hormone-sensitive cancers.

Evening primrose oil, rich in the fatty acid gamma-linolenic acid, has a devoted following and a poor record. The randomized trials that exist, including a well-conducted one from the 1990s and smaller later studies, found no meaningful reduction in hot flashes compared with placebo. It is largely harmless, with occasional digestive upset, and it may raise bleeding risk alongside anticoagulant medicines.

St John’s wort is in a different lane. Its evidence concerns low mood rather than flashes, and several trials support a modest antidepressant effect for mild to moderate depression. The catch is pharmacological: the herb speeds up liver enzymes that clear many prescription medicines, including some contraceptives, blood thinners, heart drugs and antidepressants, which can make those medicines fail or cause dangerous interactions. Anyone taking a prescription should not add it without their clinician’s sign-off.

Dong quai, wild yam, maca and ginseng complete the list. Dong quai failed its main randomized trial for hot flashes and can increase sun sensitivity and bleeding. Wild yam contains a compound that laboratories can turn into progesterone, but the human body cannot, so creams and capsules provide no hormone. Maca has a handful of tiny trials with inconsistent results. Ginseng has not reduced hot flashes in trials, though some studies suggest small improvements in mood or general wellbeing.

The honest grade for this whole group is low-certainty evidence, with St John’s wort standing out for a real effect on mood and a real interaction risk.

Vitamins and minerals: what they can and cannot do

Vitamins appear in nearly every “menopause formula,” and here the evidence splits cleanly between what they do for long-term health and what they do for daily symptoms.

Bone is where they earn their keep. Estrogen restrains the cells that break down bone, and when it falls, breakdown outpaces rebuilding. A woman can lose a substantial share of her bone density in the five to seven years after her final period, which is why postmenopausal women are the largest group affected by osteoporosis. Calcium and vitamin D are the raw materials; the NIH Office of Dietary Supplements and the NHS both advise meeting recommended intakes, preferably through food for calcium, with vitamin D supplementation sensible for most adults in winter months and year-round for people with little sun exposure or darker skin. The evidence that correcting a deficiency protects bone is strong. The evidence that supplements help women who are already replete is weaker, and more calcium than the body needs has been linked in some observational studies to kidney stones, so more is not better.

For hot flashes, the vitamin story is nearly empty. Vitamin E showed a statistically detectable but clinically trivial reduction in one often-quoted trial. Vitamin D has no demonstrated effect on flashes. The B vitamins, despite confident claims about “energy” and “hormone balance,” have no trial support for menopause symptoms unless a deficiency is present. Omega-3 fatty acids were tested in a rigorous NIH-funded trial and did not beat placebo for hot flashes, though they remain reasonable for heart health as part of a fish-rich diet.

Magnesium is the current darling of sleep marketing. Small studies hint at help for sleep quality in people with low intake, and it is generally safe, but direct trials in menopausal women are sparse. Iron matters mainly during perimenopause, when heavy periods can quietly drain stores; a blood test, not a guess, should decide whether you need it.

Menopause supplements at a glance: a trial-based comparison

The table below condenses the main products into one view. “Evidence grade” refers to the strength and consistency of randomized trials, not to how popular the product is. Where a supplement has a genuine role for one outcome but not another, both are listed.

Supplement	Main claim	What randomized trials show	Evidence grade	Key safety notes
Black cohosh	Fewer hot flashes	Pooled trials show no difference from placebo	Moderate certainty of little or no effect	Rare liver injury reports; avoid with liver disease
Soy isoflavones	Fewer hot flashes	Inconsistent; small average benefit in some analyses after 12+ weeks	Low to moderate	Caution with hormone-sensitive cancer; soy foods safe for most
Red clover	Fewer hot flashes	Mixed, pooled effect near zero	Low	Isoflavone cautions as above
Evening primrose oil	Fewer hot flashes	No benefit over placebo	Moderate certainty of no effect	Bleeding risk with anticoagulants
St John’s wort	Better mood	Modest benefit for mild to moderate depression	Moderate	Many serious drug interactions
Vitamin D and calcium	Bone protection	Reduce bone loss and fractures when intake is low; no effect on hot flashes	High for bone, none for flashes	Excess calcium linked to kidney stones
Omega-3	Fewer hot flashes, mood	No benefit for flashes in a rigorous trial	Moderate certainty of no effect	Generally safe
Vitamin E	Fewer hot flashes	Tiny reduction of doubtful meaning	Low	High intakes may raise bleeding risk
Maca, ginseng, dong quai, DHEA	Various	Small or absent trials; mostly null	Very low	DHEA is a hormone and needs medical oversight

Read across a row and the pattern is clear: the products most heavily advertised for hot flashes have the least to show, while the quiet pairing of vitamin D and calcium has the strongest case, for a different outcome entirely.

Are menopause supplements safe? Regulation, quality and interactions

In the United States, dietary supplements are regulated as a category of food, not medicine. Manufacturers do not have to prove a product works, or even that it contains what the label says, before selling it; the FDA acts mainly after problems surface. That framework has consequences a glossy label will not mention.

Content varies. Independent testing of herbal products has repeatedly found capsules with far less active compound than declared, and occasionally a different plant altogether. Black cohosh has a documented history of adulteration with cheaper Asian species of the same genus, which some researchers suspect may explain a share of the liver reports. Looking for a third-party quality seal from an independent testing organization reduces, though does not remove, that uncertainty.

Interactions are the second concern. St John’s wort is the most hazardous, able to blunt the effect of medicines ranging from certain heart drugs to some cancer treatments. Isoflavone supplements may interfere with thyroid hormone absorption in people who already have low thyroid function. Several herbs, including evening primrose, dong quai, ginseng and high-dose vitamin E, can add to the bleeding tendency of anticoagulants or aspirin. Anyone preparing for surgery is usually asked to stop herbal products beforehand for exactly this reason.

The third concern is the hidden ingredient. Products marketed for “hormone balance” have on occasion been found to contain undeclared pharmaceutical compounds. Multi-ingredient “menopause complexes” compound the problem because a reaction cannot be traced to one component.

None of this makes supplements uniquely dangerous; most women who take black cohosh or soy isoflavones for a few months come to no harm. It does mean that “natural” is a marketing word, not a safety grade, and that your clinician and pharmacist need to know everything in your cabinet, including the gummies.

Why placebo responses are so large in hot flash trials

Here is the number that reframes every testimonial: in placebo-controlled hot flash trials, women given a dummy pill typically report a 30 to 50 percent reduction in flashes. That is not fraud and it is not imagination. It is what happens when a fluctuating symptom meets expectation, attention and time.

Hot flashes wax and wane on their own. Women tend to enroll in a study, or buy a supplement, when symptoms are at their worst, and the natural drift back toward average looks like improvement. Statisticians call this regression to the mean. Layered on top is the expectation effect, which is unusually strong for symptoms routed through the brain’s temperature center and stress circuits; believing relief is coming genuinely changes how the body registers a flash. Keeping a symptom diary, as trial participants do, also shifts behavior in ways that reduce triggers.

This is why a product can feel like it works for an individual while failing to beat placebo across a trial. The supplement did not do nothing; the placebo did the same thing. For a woman weighing whether to spend money on black cohosh, the practical implication is simple. Any benefit she experiences may be real in her life and still not be pharmacological, and the same benefit might be available from the expectation and routine of almost any ritual, including a nightly cup of herbal tea with no active ingredient.

The flip side is encouraging. Treatments that do beat placebo, such as hormone therapy or the newer neurokinin-receptor blockers, show reductions of 60 to 80 percent in trials, far beyond the placebo floor. When a product’s advertised effect sits inside the placebo range, that tells you something about where the evidence stands.

Diet and lifestyle in perimenopause: what has actual evidence

If supplements are the pharmacy aisle’s answer, the kitchen and the calendar have quieter but better-supported ones.

Diet first. There is no single “perimenopause diet” with trial proof, but the Mediterranean pattern, built on vegetables, legumes, whole grains, olive oil, fish and modest dairy, has the strongest long-term evidence for the risks that rise after menopause: heart disease, type 2 diabetes and weight gain around the middle. Adequate protein spread through the day helps preserve muscle, which declines faster once estrogen falls. Calcium-rich foods such as yogurt, sardines with bones, fortified plant milks and leafy greens do the work most calcium tablets are bought for. Whole soy foods fit naturally into this pattern and are a reasonable, food-based way to test whether isoflavones suit you.

Alcohol, caffeine, spicy food and hot rooms are common hot flash triggers, and tracking which ones apply to you is more useful than cutting all of them. Smoking is linked to earlier menopause and more severe flashes, and quitting is the single intervention with benefits in every column.

Exercise does not reliably reduce the number of hot flashes in trials, a finding that surprises many people. It does improve sleep, mood, weight stability and bone strength, and resistance training in particular slows the bone loss of the early postmenopausal years. Yoga and paced breathing show small benefits for distress around flashes rather than their frequency.

Cognitive behavioral therapy deserves special mention. Randomized trials, including several in the UK, show that a short structured course reduces how much hot flashes interfere with daily life and improves sleep, and NHS guidance lists it as a recommended option. Clinical hypnosis has shown a reduction in flash frequency in randomized trials as well. Neither comes in a bottle, which is probably why neither trends.

Menopause supplements compared with prescription treatment

The fair comparison for any menopause supplement is not “versus nothing” but “versus what a clinician could offer.” On that yardstick, the gap is wide.

Hormone therapy, meaning estrogen with progesterone for women who have a uterus or estrogen alone for those who do not, reduces hot flash frequency by roughly 75 percent in randomized trials and is the only treatment with strong evidence for vaginal dryness, sleep disturbance driven by night sweats and bone protection together. The NHS and Mayo Clinic describe it as the most effective treatment, with risks that depend on age, timing, health history and formulation. Low-dose vaginal estrogen treats genitourinary symptoms with minimal absorption into the bloodstream. Whether hormone therapy is appropriate, in what form and for how long is an individual medical decision, and recent US label changes have not altered that principle.

For women who cannot or do not want to take hormones, the non-hormonal prescription list has lengthened. Fezolinetant and a second drug in the same class block the neurokinin-3 pathway that misfires in the brain’s thermostat, cutting flashes substantially in large randomized trials; both require liver blood tests during use. Certain antidepressants of the SSRI and SNRI classes, the anticonvulsant gabapentin and the bladder medicine oxybutynin each have randomized evidence of moderate benefit and are listed in guideline documents, even though hot flashes are not on every label. Using them this way is a decision for the prescribing clinician, who weighs evidence against each woman’s other conditions and medicines.

Against that menu, black cohosh and soy isoflavones offer, at best, a small and uncertain effect. That does not make them useless for a woman with mild symptoms who prefers to start gently. It does mean that moderate to severe symptoms, or symptoms that disrupt work and sleep, are a reason to ask about treatments that have cleared the placebo bar rather than to keep rotating bottles.

Common myths about menopause supplements, corrected

“Black cohosh is a natural estrogen.” It is not. Current research finds no estrogenic activity; whatever it does appears to involve brain signaling, and trials show no reliable effect on hot flashes. Calling it a phytoestrogen is outdated.

“Soy causes breast cancer.” Observational studies of soy foods, including in women who have had breast cancer, consistently show no increase in risk and in some populations a lower one. The open question is high-dose isoflavone supplements, not tofu. That uncertainty is a reason for women with hormone-sensitive cancer to ask their oncologist, not a reason for anyone to fear edamame.

“Wild yam cream is natural progesterone.” Wild yam contains diosgenin, which chemists can convert to progesterone in a laboratory. Human skin and digestion cannot perform that conversion. Any cream that does contain progesterone has had the hormone added to it and should be regulated as a medicine.

“If it’s sold in a pharmacy it has been tested.” Dietary supplements reach the shelf without pre-market testing for effectiveness or content. Third-party quality seals verify identity and purity, not benefit.

“Hormone balancing blends fix the root cause.” Menopause is not a deficiency to be corrected back to a 30-year-old’s hormone profile, and no supplement has been shown to alter estrogen levels meaningfully. “Balance” is a marketing term without a measurable definition.

“Hot flashes stop after a year or two, so just ride it out.” Median duration in a large US cohort was about seven years, longer for women whose flashes began early. Waiting is a legitimate choice; waiting on a false timetable is not.

“A positive customer review is evidence.” With placebo responses of 30 to 50 percent, thousands of sincere testimonials are exactly what an inert product would generate. Only comparison against placebo can separate the pill from the hope.

When to see a doctor about menopause symptoms or supplements

Supplements sit in the self-care space, which is precisely why a few situations should move you out of it and into a clinic.

Bleeding is the firmest line. Any vaginal bleeding after twelve months without a period, bleeding after sex, periods that soak through protection hourly, or cycles arriving closer than every three weeks need prompt evaluation, because the cause ranges from benign polyps to conditions where early diagnosis matters. Spotting during perimenopause is often harmless, but the pattern decides, and only an examination can tell.

Liver warning signs while taking black cohosh or any herbal product call for stopping the product and seeking care the same week: yellowing of the skin or whites of the eyes, dark urine, pale stools, pain under the right ribs, or unexplained nausea and exhaustion. New bruising or prolonged bleeding on herbs that affect clotting, especially alongside anticoagulants, deserves the same urgency.

Symptoms that stop being a nuisance and start running your life are a medical matter, not a willpower test. Flashes that wake you most nights, mood changes that feel unlike you, thoughts of self-harm, chest pain, palpitations that come with faintness or breathlessness, or unexplained weight loss are not menopause by default and should be assessed.

Timing matters too. Menopause symptoms before 45, and certainly before 40, warrant evaluation for premature ovarian insufficiency and discussion of bone and heart protection. A personal or family history of breast cancer, blood clots, liver disease or thyroid disorder changes which supplements and prescriptions are reasonable, and that conversation should happen before the first capsule, not after.

Bring the bottles, or photographs of their labels, to the appointment. Every decision about starting, combining or stopping a supplement alongside prescribed medicine belongs with your treating clinician, who can see the whole picture that a product label cannot.

Frequently asked questions

Does black cohosh work for hot flashes?

Randomized trials pooled together show black cohosh performs about the same as placebo for the number and severity of hot flashes. A few European studies using one specific extract reported benefit, but the larger and better-designed trials, including a year-long NIH-funded study, found no effect. It is generally safe for short-term use, with rare reports of liver injury. If you want to try it, tell your clinician, especially if you have liver disease.

Are soy isoflavone supplements effective for menopause symptoms?

The evidence is mixed and the effect, where found, is small. Some meta-analyses report a modest reduction in hot flash frequency after at least 12 weeks; the 2013 Cochrane review found no conclusive benefit. Whole soy foods are safe for most people and a reasonable place to start. Women who have had hormone-sensitive breast cancer should discuss concentrated isoflavone supplements with their oncology team before using them.

What are the common symptoms of postmenopause?

After the final period, hot flashes and night sweats often continue for years, and vaginal dryness, urinary urgency and discomfort during sex become more common as tissue thins. Sleep disruption, mood changes, joint aches and changes in skin and hair are frequently reported. The most significant silent change is accelerated bone loss in the first several years, which is why bone health deserves attention even when symptoms feel mild.

Is spotting a common symptom during perimenopause?

Light spotting and irregular bleeding are common in perimenopause because ovulation becomes unpredictable and the uterine lining sheds on a changed schedule. Certain patterns, however, always need evaluation: very heavy bleeding, bleeding after sex, periods closer than three weeks apart, or any bleeding after twelve months without a period. A clinician can distinguish normal transition changes from causes such as polyps or lining overgrowth.

Is it normal to experience perimenopause at 40?

Yes, perimenopause commonly begins in the early to mid-40s, and symptoms at 40 are within the normal range. Menopause itself before 45 is classed as early, and before 40 as premature ovarian insufficiency, which warrants medical evaluation because long-term bone and heart health can be affected. If your periods have become irregular at 40 along with hot flashes or sleep changes, mention it at your next visit.

What is the best diet to follow during perimenopause?

No single diet has trial proof for perimenopause symptoms, but a Mediterranean-style pattern has the strongest evidence for the heart, metabolic and weight risks that rise after menopause. Prioritize vegetables, legumes, whole grains, olive oil, fish and adequate protein, include calcium-rich foods daily, and consider whole soy foods. Tracking personal hot flash triggers such as alcohol, caffeine and spicy food is more useful than cutting everything.

Which vitamins help with menopause?

Vitamin D and calcium have strong evidence for slowing bone loss when intake is low, which matters because bone density falls quickly after the final period. No vitamin has convincing evidence for hot flashes; vitamin E shows a trivial effect and B vitamins none unless you are deficient. Iron may be needed during perimenopause if heavy periods have lowered your stores, but a blood test should guide that decision.

Can I take menopause supplements with hormone therapy or antidepressants?

Some combinations are risky. St John’s wort speeds up the breakdown of many medicines, including hormones and several antidepressants, and should not be combined without medical advice. Isoflavone supplements may affect thyroid medicine absorption, and several herbs add to bleeding risk with anticoagulants. Always bring your full supplement list to the clinician who prescribes your medicines; the decision on combining them belongs there.

Why do menopause supplements seem to work for some women?

In placebo-controlled trials, women taking a dummy pill report 30 to 50 percent fewer hot flashes, driven by natural fluctuation, expectation and the attention of tracking symptoms. A supplement can therefore produce genuine relief for an individual without having any pharmacological effect beyond placebo. That relief is real in daily life, but it is not evidence that the ingredient itself is doing the work.

What is more effective than menopause supplements for hot flashes?

Hormone therapy reduces hot flash frequency by roughly 75 percent in randomized trials and remains the most effective option for suitable women. Non-hormonal prescription choices include newer medicines that block the neurokinin-3 pathway in the brain’s thermostat, as well as certain antidepressants, gabapentin and oxybutynin, each with moderate trial evidence. Cognitive behavioral therapy and clinical hypnosis also beat placebo. Which is right for you is a decision for your clinician.

References

• Soy: Usefulness and Safety, NIH National Center for Complementary and Integrative Health
• Menopause: Treatment, NHS
• Perimenopause: Age, Stages, Signs, Symptoms and Treatment, Cleveland Clinic

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.